MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: Allgemeines0jzhyaAntwortenAntworten: 0jzhya <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 15:03 Uhr</div>[url=https://www.sciencedirect.com/science/article/abs/pii/037811199400784P]Zoya Demidenko[/url]: Scholar in Tumor Studies [url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126]Zoya Demidenko[/url] is a notable scientist connected with the Unit of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she worked at the NIH and New York Medical College, building a solid base in biomedical investigation. Her academic contributions covers multiple pivotal areas, including the PI3K/AKT/mTOR signaling cascade, cell cycle regulation, biological aging, and cancer biology. To date, she has written over 46 scientific publications, which have garnered upwards of 4,100 references — a indicator to the impact of her work. Among her most notable contributions concerns elucidating the mechanisms of cell aging. Her work revealed that when the cell cycle is blocked yet cellular expansion proceeds, the cells enter senescence. Importantly, [url=https://scholargps.com/scholars/59798749410547/zoya-n-demidenko]Zoya Demidenko[/url] demonstrated that this process is controlled with drugs using substances such as rapamycin. [url=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012]Zoya Demidenko[/url] has additionally added substantially to tumor management investigation, notably in the field of cyclotherapy — a approach aimed at shielding normal cells from chemotherapy whilst leaving malignant cells exposed. This strategy offers considerable potential for diminishing the toxic effects of cancer treatment. Across her professional journey, Demidenko has collaborated with top researchers worldwide, among them Dr. Mikhail Blagosklonny. Her publications is published in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: With an h-index of 33, [url=https://www.oncotarget.com/article/4836/]Zoya Demidenko[/url] ranks as a influential figure in current biomedical science, with her findings go on to shape our knowledge of how cells age, resist treatment, and the ways in which cancer may be better targeted. https://www.oncotarget.com/article/4836/</blockquote><br> Abbrechen
